Gap between clinical guidelines and practice: The case of aldosterone-antagonists in patients with myocardial infarction

International Journal of Cardiology

Volumn 172, Issue 1, 2014, Pages

  Shore, Supriya ^a,d,e   Maddox, Thomas M ^a,d,e   Tang, Fengming ^b   Jones, Philip G ^b   Lanfear, David E ^c   Ho, P Michael ^a,d,e  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^c HENRY FORD HOSPITAL   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e Department of Medicine   (United States)

Author keywords

Aldosterone antagonist; Clinical guidelines and practice; Myocardial infarction

Indexed keywords

ALDOSTERONE ANTAGONIST; CREATININE; HEMOGLOBIN A1C; LOOP DIURETIC AGENT; POTASSIUM;

ACUTE HEART INFARCTION; CLINICAL PRACTICE; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DRUG UTILIZATION; FOLLOW UP; HEART EJECTION FRACTION; HEART FAILURE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LETTER; MULTICENTER STUDY (TOPIC); POTASSIUM BLOOD LEVEL; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL;

ALDOSTERONE ANTAGONIST; CLINICAL GUIDELINES AND PRACTICE; MYOCARDIAL INFARCTION;

AGED; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MINERALOCORTICOID RECEPTOR ANTAGONISTS; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES AS TOPIC; REGISTRIES;

EID: 84894076209     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.12.076     Document Type: Article

References (9)

1. J.L. Anderson, C.D. Adams, and E.M. Antman et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine J Am Coll Cardiol 50 2007 e1 e157
2. P.T. O'Gara, F.G. Kushner, and D.D. Ascheim et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 127 2013 529 555
3. A.N. Rassi, M.A. Cavender, and G.C. Fonarow et al. Temporal trends and predictors in the use of aldosterone antagonists post-acute myocardial infarction J Am Coll Cardiol 61 2013 35 40
4. J.A. Spertus, E. Peterson, and J.S. Rumsfeld et al. The Prospective Registry Evaluating Myocardial Infarction: Events and Recovery (PREMIER) - evaluating the impact of myocardial infarction on patient outcomes Am Heart J 151 2006 589 597
5. S.V. Arnold, P.S. Chan, and P.G. Jones et al. Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH): design and rationale of a prospective multicenter registry Circ Cardiovasc Qual Outcomes 4 2011 467 476
6. B. Pitt, W. Remme, and F. Zannad et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 2003 1309 1321
7. T.M. Maddox, and P.M. Ho Medication adherence and the patient with coronary artery disease: challenges for the practitioner Curr Opin Cardiol 24 2009 468 472
8. M.T. Roe, E.D. Peterson, and L.K. Newby et al. The influence of risk status on guideline adherence for patients with non-ST-segment elevation acute coronary syndromes Am Heart J 151 2006 1205 1213
9. D.N. Juurlink, M.M. Mamdani, and D.S. Lee et al. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study N Engl J Med 351 2004 543 551